Simulations Plus (NASDAQ:SLP) Stock Rating Lowered by StockNews.com

Simulations Plus (NASDAQ:SLP) was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating in a research note issued on Monday.

A number of other brokerages also recently issued reports on SLP. BTIG Research reduced their price target on shares of Simulations Plus from $60.00 to $50.00 and set a “buy” rating on the stock in a report on Thursday, October 24th. William Blair reiterated an “outperform” rating on shares of Simulations Plus in a research report on Thursday, October 24th. JMP Securities began coverage on Simulations Plus in a report on Tuesday, July 16th. They set a “market perform” rating for the company. Finally, KeyCorp started coverage on Simulations Plus in a research report on Monday, July 29th. They set an “overweight” rating and a $47.00 target price for the company. One analyst has rated the stock with a sell rating, one has issued a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $54.50.

Simulations Plus Stock Up 4.0 %

Shares of Simulations Plus stock opened at $28.60 on Monday. The company has a market capitalization of $574.00 million, a price-to-earnings ratio of 58.37 and a beta of 0.71. The stock’s 50-day simple moving average is $31.93 and its 200-day simple moving average is $39.66. Simulations Plus has a 52 week low of $27.22 and a 52 week high of $51.22.

Simulations Plus (NASDAQ:SLP) last posted its quarterly earnings results on Wednesday, October 23rd. The technology company reported $0.06 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.02. Simulations Plus had a return on equity of 6.16% and a net margin of 14.15%. The company had revenue of $18.70 million for the quarter, compared to analysts’ expectations of $19.73 million. During the same period in the previous year, the firm earned $0.18 EPS. The firm’s revenue was up 19.9% compared to the same quarter last year. On average, equities analysts expect that Simulations Plus will post 1.11 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Walter S. Woltosz sold 20,000 shares of the firm’s stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $31.26, for a total value of $625,200.00. Following the completion of the sale, the director now directly owns 3,481,592 shares of the company’s stock, valued at $108,834,565.92. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders have sold 60,750 shares of company stock valued at $1,905,655 over the last ninety days. 20.90% of the stock is owned by insiders.

Institutional Investors Weigh In On Simulations Plus

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Azzad Asset Management Inc. ADV grew its holdings in Simulations Plus by 3.6% during the 2nd quarter. Azzad Asset Management Inc. ADV now owns 8,007 shares of the technology company’s stock valued at $389,000 after purchasing an additional 280 shares during the last quarter. InTrack Investment Management Inc grew its stake in shares of Simulations Plus by 1.1% during the second quarter. InTrack Investment Management Inc now owns 31,665 shares of the technology company’s stock valued at $1,540,000 after buying an additional 330 shares during the last quarter. Chatham Capital Group Inc. raised its holdings in shares of Simulations Plus by 1.3% in the second quarter. Chatham Capital Group Inc. now owns 34,554 shares of the technology company’s stock worth $1,680,000 after buying an additional 450 shares during the period. The Manufacturers Life Insurance Company lifted its stake in shares of Simulations Plus by 7.7% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 6,391 shares of the technology company’s stock worth $311,000 after acquiring an additional 456 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its holdings in Simulations Plus by 5.9% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 10,048 shares of the technology company’s stock valued at $414,000 after acquiring an additional 562 shares during the period. Hedge funds and other institutional investors own 78.08% of the company’s stock.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.